Business context and reporting period
Markel Group Inc. filed this Form 10-K for the fiscal year ended December 31, 2023; figures below compare full-year 2023 with full-year 2022, not Q4 alone. Markel combines specialty insurance and reinsurance, investments, and Markel Ventures, a portfolio of operating businesses. The company changed its name from Markel Corporation to Markel Group Inc. on May 26, 2023.
Financial performance and position
| Metric | 2023 | 2022 |
|---|---|---|
| Total operating revenues | $15.80 billion | $11.68 billion |
| Net income (loss) to common shareholders | $1.96 billion | $(252) million |
| Diluted earnings (loss) per share | $146.98 | $(23.72) |
| Net cash from operating activities | $2.79 billion | $2.71 billion |
| Invested assets at year-end | $30.85 billion | $27.42 billion |
| Shareholders’ equity at year-end | $14.98 billion | $13.15 billion |
- Earned premiums rose 9% to $8.30 billion. Net investment income increased to $734.5 million from $446.8 million; investment gains were $1.52 billion versus a $1.60 billion loss, largely reflecting equity-market value changes.
- Insurance underwriting profit was $162.2 million, down from $549.9 million; the segment combined ratio increased to 97.8% from 91.6%. Reinsurance recorded a $19.3 million underwriting loss versus an $83.9 million profit, with its combined ratio worsening to 101.9% from 92.1%. Consolidated underwriting profit fell 79% to $132.7 million and the combined ratio rose to 98.4% from 91.7%.
- Markel Ventures revenue increased 5% to $4.99 billion; operating income rose 35% to $437.5 million and EBITDA, a non-GAAP measure, increased 24% to $628.5 million.
- Interest expense decreased to $185.1 million from $196.1 million. Year-end senior long-term and other debt was $3.78 billion; the consolidated debt-to-capital ratio was 20%, down from 24%. The $300 million revolving credit facility had no borrowings outstanding, and the company reported covenant compliance.
- Cash, cash equivalents and restricted cash totaled $4.33 billion at year-end, compared with $5.22 billion. Operating cash flow was $2.79 billion; investing activities used $2.70 billion and financing activities used $1.00 billion. Book value per common share rose 17% to $1,095.95.
Material changes versus 2022
- The return to net income primarily reflected the swing in investment results: $1.52 billion of investment gains in 2023 compared with $1.60 billion of losses in 2022. Fixed-maturity unrealized gains in other comprehensive income also improved year over year.
- Underwriting deteriorated despite premium growth. Current accident-year loss ratios rose, and prior-year reserve benefits were much smaller: net favorable development was $38.6 million, compared with $167.4 million in 2022.
- Markel Ventures improved operating income and EBITDA as materials and freight pressures eased at many businesses; results also included a full-year contribution from Metromont.
- The company retired $250 million of 3.625% senior notes in March 2023. Common-share repurchases totaled $445.5 million, and 322,000 shares were repurchased during the year.
Outlook, risks, contingencies and unusual items
- The filing provides no specific consolidated earnings or revenue guidance. Management says it will prioritize rate adequacy over premium growth, noting varied rate trends and heightened economic and social inflation. It plans to expand State National’s program services into the U.K. in 2024.
- Management expects prior-year reserve development in 2024 to range from adverse development of 1% (about $150 million) to favorable development of 5% (about $700 million) of year-end 2023 net reserves. It says further favorable development is possible but cautions against undue reliance on that trend.
- Reserve uncertainty is a significant concern. A fourth-quarter review led to $330.7 million of adverse development in U.S. and Bermuda general and professional liability in the Insurance segment, and the Reinsurance segment recorded $57.1 million of adverse prior-year development. Management cited large claims, longer reporting tails, social and economic inflation, litigation trends and delayed claims emergence. The auditor identified underwriting loss-reserve estimation as a critical audit matter.
- The company recognized $65 million of credit losses related to fraudulent letters of credit supplied by a Vesttoo affiliate as collateral for reinsurance on two policies. Markel says this represents its full exposure on the affected recoverables and is pursuing recovery.
- Other significant risks include catastrophe severity and climate effects, reinsurance availability and collectability, broker concentration (the top five brokers generated 37% of underwriting gross premiums), and investment concentration (the ten largest equity holdings were 41% of the equity portfolio). A hypothetical 35% equity-price decline would reduce shareholders’ equity by an estimated 17.7%.
- A CVR-related lawsuit was decided in Markel’s favor in 2023; the claimant appealed. The company considers a material loss remote. The auditor issued unqualified opinions on the financial statements and internal control over financial reporting; management also concluded disclosure controls were effective.
Important facts for investors to verify
- Track reserve development and claims trends in U.S. and Bermuda general and professional liability, including how 2020–2022 accident years develop.
- Assess whether underwriting rates and terms are keeping pace with loss-cost inflation, and whether growth remains selective and profitable.
- Review investment returns separately from recurring investment income; 2023 earnings benefited materially from equity-market gains, which are volatile.
- Monitor reinsurance recoverables, collateral adequacy and any recoveries tied to the Vesttoo letters of credit; also review exposure to major reinsurers and capacity providers.
- Evaluate debt maturities, regulated-subsidiary dividend capacity, share repurchases and the liquidity needs of the holding company.